50ºF

Sweeping Senate vote sends Trump $8.3B bill to fight coronavirus

Vice President Mike Pence, center, joined at left by Dr. Deborah Birx, the coronavirus response coordinator, arrives at the Capitol to brief House members on the COVID-19 outbreak, in Washington, Wednesday, March 4, 2020. Congressional negotiators have reached agreement on an $8.3 billion bill to fund the government's response to the public health emergency. (AP Photo/J. Scott Applewhite)
Vice President Mike Pence, center, joined at left by Dr. Deborah Birx, the coronavirus response coordinator, arrives at the Capitol to brief House members on the COVID-19 outbreak, in Washington, Wednesday, March 4, 2020. Congressional negotiators have reached agreement on an $8.3 billion bill to fund the government's response to the public health emergency. (AP Photo/J. Scott Applewhite) (Copyright 2020 The Associated Press. All rights reserved)

WASHINGTON (AP) – The Senate passed an $8.3 billion measure Thursday to help tackle the coronavirus outbreak in hopes of reassuring a fearful public and accelerating the government's response to the virus, whose rapid spread is threatening to upend everyday life in the U.S. and across the globe.

The money would pay for a multifaceted attack on a virus that is spreading more widely every day, sending financial markets spiraling again Thursday, disrupting travel and potentially threatening the U.S. economy's decade-long expansion.

Thursday's sweeping 96-1 vote sends the bill to the White House for President Donald Trump's signature. Sen. Rand Paul, R-Ky., cast the sole “no” vote. The House passed the bill Wednesday by a 415-2 vote.

The plan would more than triple the $2.5 billion amount outlined by the White House 10 days ago. The Trump proposal was immediately discarded by members of Congress from both parties. Instead, they negotiated the increased figure in a burst of bipartisan cooperation that's increasingly rare in Washington.

“In situations like this, I believe no expense should be spared to protect the American people, and in crafting this package none was,” said Appropriations Committee Chairman Richard Shelby, R-Ala. “It's an aggressive plan, a vigorous plan that has received an overwhelming positive reaction.”

Trump was sure to sign the measure, which has almost universal support. It is intended to project confidence and calm as anxiety builds over the impact of the virus, which has claimed 11 lives in the U.S.

“The American people are looking for leadership and want assurance that their government is up to the task of protecting their health and safety," said Sen. Patrick Leahy, D-Vt.

The impact of the outbreak continues to mount. The British government suspended Parliament for five months in hope of limiting the spread of the virus in the United Kingdom.

The legislation would provide federal public health agencies money for vaccines, tests and potential treatments, including $300 million to deliver such drugs to those who need it. More than $2 billion would go to help federal, state and local governments prepare for and respond to the coronavirus threat. An additional $1.3 billion would be used to help fight the virus overseas.

Other dollars would be directed to help local officials prepare for the potential worsening of the outbreak and subsidize treatment by community health centers. Medicare rules would be loosened to enable remote "telehealth" consultations whereby sick people could to get treatment without visiting a doctor.

Sen. Maria Cantwell, D-Wash., whose state is at the center of the crisis, praised the bill because it “will increase access for public lab testing, help pay for isolation and quarantine, help pay for sanitizing in public areas, better track the virus and those who might come into contact with it, help labs who are trying to identify hot spots, and limit exposure."

The legislation contains a hard-won compromise that aims to protect against potential price gouging by drug manufacturers for vaccines and other medicines developed with taxpayer funds. Health and Human Services Secretary Alex Azar would have the power to make sure commercial prices are reasonable. Azar is a former drug industry lobbyist.